AUTOMRI™ comes as standard.

2014 innovation award for AUTOMRI™ technology.
Longest experience in automatic MRI detection.
AUTOMRI™ is available in all Microport™ CRM MR-conditional devices.

Defibrillator
Pacemaker

A streamlined and safe MRI pathway with AUTOMRI™.

  • AUTOMRI™ activates MRI mode upon detecting the magnetic field
  • Device switches back to its optimal pacing mode automatically
  • No intervention needed from the radiologist or cardiologist after the scan
  • Patient is ready to leave the hospital with optimal settings
The absolute patient experience.

- Patients are protected with optimal detection and treatment right up to and just after the scan
- Protects the patient by keeping their time in asynchronous mode to an absolute minimum
- Ensures patients don't leave the hospital with sub-optimal settings

Another smart device

  • AUTOMRI™ activates MRI mode upon detecting the magnetic field,
  • Device switches back to its optimal pacing mode automatically,
  • No intervention needed from the radiologist or cardiologist after the scan,
  • Patient is ready to leave the hospital with optimal settings.
Absolute patient experience.

- Patients are protected with optimal detection and treatment right up to and just after the scan,
- Protects the patient by keeping their time in asynchronous mode to an absolute minimum,
- Ensures patients don't leave the hospital with sub-optimal settings.

automri™workflow

Previous slide
Next slide
Step 1

The patient visits the cardiologist to turn AUTOMRI™ ON.

10-day scan windows.
No limitation on the number of scans during these 10 days and no need to return to the cardiologist for any additional check-ups.

Step 2

The patient enters the MRI scan.

Approaching and detecting the scanner, the device switched into asynchronous MRI mode. For tachy devices, the essential therapies (ATP + shock) are only deactivated during the scan.
Moving away from the scanner, 5 minutes after your patient leaves the MRI environment, the device switches back to the initial settings without any HCP intervention.

Step 3

The patient can go home

The patient is free to go home autonomously.

Check scan conditions for your PM/ICD patients.

Any MicroPort CRM device that is not available for selection is not compatible with MRI scans.

CAPRI STUDY

The CAPRI study is an interventional, prospective, multicenter, open label, two arms parallel non-comparative study conducted in Europe and Asia-Pacific that aims to evaluate the clinical safety and performance of MicroPort Pacing systems, using the AUTOMRI™ algorithm, under 1.5T and 3T MRI, as well as the image quality of the scans.

We take care of our patients.

We are dedicated to improving and reshaping patient lives through the application of innovative CRM science and technology.
We understand the need to inform patients about their upcoming MRI scan, accompanying them and responding to their questions and worries.

You try to access a secure page
This content is only for healthcare professionals. Are you sure you want to continue?